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Aim: To explore risk factors that may inﬂuence knee pain (KP) through central or peripheral
mechanisms.
Methods: A questionnaire-based prospective community cohort study with KP deﬁned as pain in or
around a knee on most days for at least a month. Baseline prevalence, and one year incidence and
progression (KP worsening) were examined. Central (e.g., Pain Catastrophizing Scale (PCS)) and pe-
ripheral (e.g., signiﬁcant injury) risk factors were examined. Adjusted odds ratio (OR) and 95% conﬁdence
interval (CI) were calculated using logistic regression. Proportional risk contribution (PRC) was estimated
using receiver-operator-characteristic (ROC) analysis.
Results: Of 9506 baseline participants, 4288 (45%) had KP (men 1826; women, 2462). KP incidence was
12% (men 11%, women 13%), and KP progression 19% (men 16%, women 21%) at one year. While both
central and peripheral factors contributed to prevalence, central factors contributed more to progression,
and peripheral factors more to incidence of KP. For example, although PCS (OR 2.06, 95% CI 1.88e2.25)
and injury (5.62, 4.92e6.42) associated with KP prevalence, PCS associated with progression (2.27, 1.83
e2.83) but not incidence (1.14, 0.86e1.52), whereas injury more strongly associated with incidence
(69.27, 24.15e198.7) than progression (2.52, 1.48e4.30). The PRC of central and peripheral factors were
19% and 23% for prevalence, 14% and 29% for incidence, and 29% and 5% for progression, respectively.
Conclusions: Both central and peripheral risk factors inﬂuence KP but relative contributions may differ in
terms of development (mainly peripheral) and progression (mainly central). Further study of such
relative contributions may inform primary and secondary prevention strategies.
© 2018 The Author(s). Published by Elsevier Ltd on behalf of Osteoarthritis Research Society
International. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).: W. Zhang, Academic Rheu-
ttingham NG5 1PB, UK.
(A. Sarmanova), gwen.
n.richardson@nottingham.ac.
A.M. Valdes), david.walsh@
tingham.ac.uk (W. Zhang),
er Ltd on behalf of Osteoarthritis RKey messages
 Knee pain (KP) is associated with both central and pe-
ripheral risk factors
 Peripheral risk factors such as joint injury contributemore
to the development of KP
 Central factors such as pain catastrophising and depres-
sion appear the main drivers for the progression of KPesearch Society International. This is an open access article under the CC BY license
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Approximately 25% of people aged over 55 have chronic knee
pain (KP)1. KP is multifactorial and may be caused predominantly
by peripheral risk factors such as knee osteoarthritis (OA)2, or by
alteration in central pain modulatory pathways as in ﬁbromyalgia3.
KP is a clinical malady related to but not fully explained by knee OA
in middle-aged and older adults4e6. This may explain in part the
common discordance between KP and structural knee OA7. Risk
factors for KP and knee OA may differ, and consideration of both
peripheral and central risk factors is important in clinical assess-
ment and to inform the management plan8.
KP affects quality of life9, causes disability10 and associates with
increased mortality11. Despite treatment attempts an increasing
number of people undergo total joint replacement (TJR). However,
15e30% of those undergoing TJR subsequently still experience
chronic KP12 suggesting that central pain modulation is an impor-
tant driver of their pain.
The contribution of individual risk factors has been examined
previously. However, systematic reviews emphasise that many risk
factors have been examined predominantly in cross-sectional
studies, and persuasive evidence for causal relationships from
cohort studies examining incidence and progression of KP is
limited13e16. For example, only a few studies report an association
between depression/anxiety and incident KP, and between wide-
spread pain (WSP), previous knee injury and progression of
KP14,16e19.
Understanding mechanisms of KP has important implications
for targeted management of chronic KP and for predicting response
to existing therapies20e22. The current study aimed to explore risk
factors that may inﬂuence prevalent KP, incident KP and progres-
sion of KP through either peripheral or central mechanisms in a
community-based cohort study.
Methods
This study was approved by Nottingham University Hospitals
NHS Trust and the Nottingham Research Ethics Committee 1 (Ref
14/EM/0015).
Study design and participant selection
Participants were selected from the KP and Related Health in the
Community Study (KPIC), an ongoing prospective cohort study
aimed to determine the natural history of KP including prevalence,
incidence, progression and associated risk factors in community-
derived adults23. At baseline 40,505 questionnaires were mailed
and 9506 men and women aged 40 years replied. One year later
another questionnaire was posted to the 6716 live participants who
indicated willingness to receive further questionnaires. Responders
to the Year 1 questionnaire (n ¼ 4737) reported a higher frequency
of KP and pain severity at baseline compared to non-responders
(Appendix 1). Exclusion criteria at baseline were known terminal
illness, severe psychiatric illness or dementia, or any other condi-
tion or circumstance considered by their General Practice to make
them unsuitable to receive the questionnaire.
For the current study we constructed two sub-cohorts from the
Year-1 questionnaire responders1: an incidence cohort comprising
participants with no KP at baseline and therefore at risk of devel-
oping new-onset KP (n ¼ 2341) during follow-up; and2 a progres-
sion cohort comprising participants with KP at baseline and
therefore at risk for progression (n ¼ 2396). An overview of
recruitment is presented in Appendix 2.Pain measures
KP was deﬁned as pain in or around a knee on most days for at
least a month ever24. Current KPwas deﬁned as pain on most days
of the past month. Prevalence of KP was deﬁned by satisfying the
KP criterion at baseline. Incident KP was deﬁned as no KP at
baseline but KP reported at follow-up. Worsening of KP was
deﬁned using the question “Since it has started, do you think the
severity of your KP has overall greatly improved/slightly improved/
remained the same/worsened” (Patient Global Assessment (PGA)).
Average pain intensity in the past month was assessed on a 0e10
numerical rating scale (NRS).
Neuropathic-like KP was determined using the Pain-DETECT
questionnaire modiﬁed for use in knee OA (mPDQ score 19)25.
KP was also classiﬁed as intermittent and/or constant using the
Measure of Intermittent and Constant Osteoarthritis Pain
(ICOAP)26. A summative score for each sub-scale was calculated and
standardised into 0e100 scale as recommended. Tertiles were
calculated for baseline scores of people with KP.
GP-diagnosed OA was self-reported and deﬁned using the
question “Have you ever been diagnosed by your doctor as having
osteoarthritis of the knee?”Risk factors
Age, gender, weight, height and data on other risk factors were
included in the questionnaire. Risk factors were divided into three
main groups interpreted by the authors as central (related to pain
perception and pain physiology), peripheral (related to structural
changes in the knee joint) and others (mixed inﬂuence).Central risk factors
 WSP was identiﬁed using a diagrammatic manikin and deﬁned
as concurrent pain experienced within the past 4 weeks axially,
above and below the waist, and on both sides of the body27.
Current KP was not counted for this.
 The Hospital Anxiety and Depression Scale (HADS) and Pain
Catastrophizing Scale (PCS) scores were each summated as
recommended28,29. A score on HADS-A or HADS-D 8 was used
to indicate anxiety or depression28. Tertiles of the PCS score
were calculated from the whole sample including those with
and without KP.Peripheral
 Amajor/signiﬁcant knee injurywas deﬁned as a history of knee
injury that required seeing a doctor (leg fracture was recorded
separately and not included in this deﬁnition).
 Self-reported frontal plane knee alignment was assessed in
both knees using a validated line diagram instrument30. Par-
ticipants separately reported their current and early adult life (in
their 20's) alignment. Constitutional malalignment was deﬁned
as bilateral varus/valgus malalignment (mild or severe) in their
20's.
 High risk occupation was classiﬁed based on published evi-
dence31 (Appendix 3). Each listed occupation per individual was
analysed and the data dichotomised into high- or low-risk
groups.
 2D:4D (index:ring ﬁnger length) ratio was self-reported using a
validated line-drawing instrument32. Type 3 pattern (index
shorter than ring ﬁnger) is a risk factor for knee OA32.
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 Nodal OA, which has high heritability and increases risk of knee
OA, was determined using a validated line diagram and classi-
ﬁed as present in those reporting nodes on at least two rays of
each hand33.
 Comorbidities:History or current evidence of comorbidities was
recorded for the following: cardiovascular disease (high
cholesterol*, heart attack*, angina*, hypertension*), lung disease
(chronic obstructive pulmonary disease (COPD), asthma, idio-
pathic pulmonary ﬁbrosis), endocrine disease (diabetes*, un-
deractive/overactive thyroid, thyroiditis), non-restorative pain
disorders (irritable bowel syndrome*, ﬁbromyalgia*, chronic
fatigue syndrome*), liver disease (cirrhosis, hepatitis, non-
alcoholic fatty liver disease), chronic kidney disease/failure
(CKD), central nervous system disorders (stroke*, multiple
sclerosis), chronic rheumatic conditions (rheumatoid arthritis,
lupus, psoriatic arthritis, ankylosing spondylitis), and gout. In
the questionnaire a list of speciﬁc conditions (marked *above)
and an open “others” question were provided. All conditions
were then grouped according to the system as listed above. A
comorbidity count was calculated as a total number of affected
systems (0e9).
 Analgesics: Use of prescribed and/or over-the-counter analge-
sics (e.g., paracetamol; non-steroidal anti-inﬂammatory drugs
(NSAIDs), including COX-2 selective inhibitors; opioids) was
self-reported.
Statistical analysis
Sample size
Sample size was calculated based on a multivariable logistic
regressionmodel34, considering 80% powerwith 5% type I error and
the following assumptions1: an odds ratio (OR) of 1.4 for aweak but
signiﬁcant association (because a weak association requires larger
sample size)34; and2 a moderate correlation between covariates
(r ¼ 0.5)35. Based on the above assumptions, 452 participants were
required for a cross sectional study for the association given a 25%
prevalence of KP in the general population1, 2548 participants were
required for an incidence cohort study according to an annual KP
incidence of 3%, and 676 participants were required for a progres-
sion cohort study according to an annual rate of worsening of KP of
14%36.
Analysis
The primary focus was to determine multiple risk factors asso-
ciated with KP. At baseline potential risk factors for prevalent KP
were examined using multivariable logistic regression analysis. OR
and 95% conﬁdence interval (CI) were estimated with adjustment
for age, gender, body mass index (BMI). Adjusting all exposures by
the same group of known confounding factors makes adjusted ORs
comparable between exposures andwouldminimize bias related to
“Table II Fallacy”37. At follow-up risk factors for incident KP or
worsening KP were examined using multivariable logistic regres-
sion analysis, all participants having the same one year follow-up
period.
Sensitivity analysis was undertaken using an alternative deﬁ-
nition of KP worsening, deﬁned by a signiﬁcant increase from
baseline in KP severity on NRS. A signiﬁcant change from the
baseline was calculated using the least signiﬁcant criterion (LSC)38.
We used receiver-operator-characteristic (ROC) curves and
areas under the curve (AUC) to examine proportional risk contri-
bution (PRC) of central and peripheral risk factors. ROC curves werebased on the multivariable logistic regression model with preva-
lent/incident/worsening KP as an outcome. Firstly, we built the full
risk model for each outcome with a ROC curve (AUCf). Secondly, we
removed the exposure(s) of interest to examine the contribution of
the exposure (s) removed through the reduction of the ROC curve,
i.e., the partial AUC (AUCp). Thirdly we calculated the PRC using the
following formula: PRC ¼ AUCfAUCpAUCf0:5 , where 0.5 is the AUC under the
diagonal line of the ROC curve indicating no discrimination at all by
all included risk factors. The full model included central (WSP,
HADs, PCS), peripheral (history of signiﬁcant injury, early life mal-
alignment, current mal-alignment, high risk occupation) and other
risk factors (age, gender, BMI, number of comorbidities, nodal hand
osteoarthritis). In addition, the full model for incident and wors-
ening KP included new knee injury (past 12months) as a peripheral
risk factor.
The described models for PRC are different from the models
used to estimate associations (age, gender and BMI adjusted)
because of the different purposes of the two models. While the
latter model aimed to make a comparison between different risk
factors, the models used to estimate PRC aimed to examine the
contribution of central and peripheral risk factors in the context of
all possible risk factors.
All analyses were undertaken using SAS 9.4.
Results
Demographics of participants
Characteristics of the study population are presented in Table I.
The baseline mean age was 62.1 (range 40e86) years, 57% were
women, and the mean BMI was 27.31 (SD 5.30, range 13e74). Prev-
alence of KPwas 45% (men, 44%;women, 46%), prevalence of current
KP was 28% (men 27%, women 29%), and 14% had GP-diagnosed OA
(men 12%, women 15%). People with KP used more NSAIDs and
opioids than those without (6% vs 2% for prescribed NSAIDs, 22% vs
9% for over-the-counter NSAIDs, 15% vs 5% for opioids). More than
half the studypopulation reportedoneormore comorbidities (61%of
peoplewithKP, 53%of thosewithout). Themostprevalent conditions
in KP participants were cardiovascular diseases (54%), non-
restorative pain disorders (16%), and endocrine diseases (15%).
Detailed comorbidity results are presented in Appendix 4.
Incidence of KP during the 1 year follow-upwas 12% (285/2341).
This was similar in men (11%) and women (13%). During the one
year follow-up, 19% (453/2396) reported worsening of KP (men
16%, women 21%).
Risk factors for prevalent KP
Both central and peripheral risk factors associated with KP
(Table II, Appendix 5). Among central factors, WSP was the stron-
gest (OR 3.02, 95% CI 2.71, 3.37), followed by depression (OR 2.40,
95% CI 2.14, 2.70 for HAD-D8), pain catastrophizing (OR 2.06, 95%
CI 1.88, 2.25 for PCS9) and anxiety (OR 1.87, 95% CI 1.71, 2.06 for
HAD-A8). Among peripheral factors, previous knee injury was the
strongest (OR 5.62, 95% CI 4.92, 6.42), followed by constitutional
mal-alignment (OR 1.49, 95%CI 1.18, 1.88 for varus, and OR 1.72, 95%
CI 1.25, 2.36 for valgus) and high risk occupation (OR 1.43, 95% CI
1.31, 1.56). Among other risk factors nodal hand OA (OR 1.89, 95% CI
1.64, 2.17), comorbidity (OR 1.29, 95% CI 1.18, 1.42 for any comor-
bidity), gender and BMI associated with KP.
The AUC for the full model including central, peripheral and
other factors was 0.76 (0.74, 0.77). The PRC of central and peripheral
factors to the full model was 19% and 23%, respectively, and
contribution of other factors was 27% (Fig. 1). Detailed ROC analyses
Table I
Characteristics of the study population (questionnaire survey)
Baseline Year-1
Total No KP KP Total Incident KP Worsening KP
N 9506 5218 4288 4737 285 453
Age (years), mean (SD) 62.10 (10.56) 62.33 (10.69) 61.82 (10.40) 63.95 (10.13) 62.38 (10.09) 63.03 (10.19)
Age categories
40e49 1442 (15.17) 793 (15.20) 649 (15.14) 640 (13.51) 39 (13.68) 53 (11.70)
50e59 2297 (24.16) 1210 (23.19) 1087 (25.35) 1112 (23.47) 70 (24.56) 115 (25.39)
60e69 3094 (32.55) 1658 (31.77) 1436 (33.49) 1697 (35.82) 96 (33.68) 157 (34.66)
70e79 2339 (24.61) 1359 (26.04) 980 (22.85) 1167 (24.63) 76 (26.67) 115 (25.39)
80 276 (2.90) 162 (3.10) 114 (2.66) 122 (2.57) 4 (1.40) 13 (2.87)
Women, n (%) 5371 (56.50) 2909 (56.03) 2462 (57.62) 2733 (57.69) 173 (60.70) 290 (64.02)
BMI (kg/m2), mean (SD) 27.31 (5.30) 26.36 (4.63) 28.47 (5.80) 27.26 (5.30) 27.36 (4.65) 29.83 (6.28)
Knee pain, n (%) 4288 (45.10) e 4288 (100) 2681 (56.60) 285 (100) 453 (100)
Current KP, n (%) 2681 (28.20) e 2681 (62.52) 1372 (28.96) 175 (61.40) 396 (87.42)
Current KP severity (NRS 0e10),
mean (SD)
1.97 (2.96) 0.09 (0.60) 4.25 (3.07) 2.06 (2.98) 3.54 (2.61) 6.26 (2.64)
GP-diagnosed knee OA (%) 1279 (13.45) 94 (1.80) 1185 (27.64) 722 (15.24) 45 (15.79) 269 (59.38)
Use of analgesics
Prescribed NSAIDs, n (%) 351 (3.69) 103 (1.97) 248 (5.78) 195 (4.12) 14 (4.91) 44 (9.71)
Opioids, n (%) 1438 (15.13) 241 (4.62) 646 (15.07) 1077 (22.73) 30 (10.53) 127 (28.04)
Over-the-counter NSAIDs, n (%) 887 (9.33) 492 (9.43) 946 (22.06) 514 (10.85) 75 (26.32) 211 (46.58)
Abbreviations: SD e standard deviation; NRS e numerical rating scale 0e10; BMI e body mass index; OA e osteoarthritis; NSAIDs e non-steroidal anti-inﬂammatory drugs;
GP -general practitioner.
Table II
Risk factors associated with prevalent, incident and worsening knee pain (KP)
Age, gender, BMI-adjusted ORs (95% CI)
Prevalence Incidence Worsening
Central risk factors
Widespread pain 3.02 (2.71; 3.37) 2.23 (1.63; 3.06) 1.68 (1.35; 2.10)
HADS anxiety score 8 1.87 (1.71; 2.06) 1.27 (0.95; 1.70) 1.68 (1.35; 2.08)
HADS depression score 8 2.40 (2.14; 2.70) 1.99 (1.38; 2.87) 1.85 (1.46; 2.34)
PCS in the highest tertile 9) 2.06 (1.88; 2.25) 1.14 (0.86; 1.52) 2.27 (1.83; 2.83)
mPDQ  19 n/ax n/ax 2.65 (1.92; 3.65)
Peripheral risk factors
Signiﬁcant injury 5.62 (4.92; 6.42) 1.08 (0.68; 1.72) 0.89 (0.70; 1.13)
New injury (past 12 months) n/a 69.27 (24.15; 198.7) 2.52 (1.48; 4.30)
Early varus malalignment 1.49 (1.18; 1.88) 1.28 (0.64; 2.57) 1.60 (0.99; 2.58)
Early valgus malalignment 1.72 (1.25; 2.36) 1.05 (0.36; 3.12) 1.64 (0.89; 3.03)
Varus malalignment 5.43 (3.44; 8.58) n/a 2.28 (1.30; 4.02)
Valgus malalignment 4.18 (2.74; 6.38) n/a 0.71 (0.37; 1.37)
High risk occupation 1.43 (1.31; 1.56) 0.99 (0.76; 1.30) 1.29 (1.04; 1.60)
2D4D ratio (type 3) 1.04 (0.95; 1.14) 1.18 (0.90; 1.54) 0.86 (0.69; 1.07)
Other risk factors
Age, mean (SD)* 1.00 (0.99; 1.00) 1.00 (0.99; 1.01) 1.01 (1.00; 1.02)
Age categories (reference age group 40e49)
50e59 1.10 (0.95; 1.26) 1.23 (0.80; 1.90) 1.29 (0.88; 1.87)
60e69 1.06 (0.93; 1.21) 1.01 (0.67; 1.53) 1.19 (0.83; 1.71)
70e79 0.93 (0.81; 1.07) 1.20 (0.78; 1.84) 1.47 (1.01; 2.14)
80 1.10 (1.01; 1.20) 0.63 (0.21; 1.84) 1.63 (0.80; 3.35)
Women, n (%)y 1.10 (1.01; 1.20) 1.15 (0.89; 1.50) 1.34 (1.07; 1.66)
BMI (kg/m2), mean (SD)z 1.08 (1.07; 1.09) 1.06 (1.03; 1.09) 1.05 (1.04; 1.07)
Nodal OA 1.89 (1.64; 2.17) 1.49 (0.99; 2.23) 1.62 (1.23; 2.14)
ICOAP intermittent in the highest tertile (7) n/ax n/ax 3.61 (2.89; 4.50)
ICOAP constant in the highest tertile (7) n/ax n/ax 3.70 (2.96; 4.63)
N of comorbidities 1.21 (1.15; 1.28) 1.31 (1.12; 1.53) 1.13 (1.00; 1.27)
Any comorbidities 1.29 (1.18; 1.42) 1.48 (1.12; 1.95) 1.29 (1.02; 1.64)
Any comorbidities  2 1.37 (1.22; 1.53) 1.26 (0.90; 1.78) 1.26 (0.98; 1.61)
Any comorbidities  3 1.68 (1.34; 2.11) 2.55 (1.41; 4.60) 0.98 (0.62; 1.54)
Any comorbidities  4 1.51 (0.80; 2.84) 8.85 (1.95; 40.16) 0.70 (0.15; 3.18)
In bold - If a 95% conﬁdence interval does not include the null value (i.e. there is a statistically meaningful or statistically signiﬁcant difference between the groups).
Abbreviations: BMI - body mass index; KP e knee pain; OR e odds ratio; CI econﬁdence interval; HADS - Hospital Anxiety and Depression Scale; PCS - Pain Catastrophizing
Scale; SD - standard deviation; PDQ e Pain DETECT questionnaire; ICOAP - Measure of Intermittent and Constant Osteoarthritis Pain.
* Adjusted for gender and BMI only.
y Adjusted for age and BMI only.
z Adjusted for age and gender only.
x mPDQ and ICOAP scores (intermittent and constant) were knee-speciﬁc, so if there was no KP at baseline, the score was 0 and therefore could not be a risk factor for
prevalent or incident KP.
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Fig. 1. Proportional risk contribution (PRC) to prevalence, incidence and progression of knee pain (KP).
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shown in Appendix 6.
Risk factors for incident KP
The strongest central factors associated with incident KP were
WSP (OR 2.23, 95% CI 1.63, 3.06) and depression (OR 1.99, 95% CI
1.38, 2.87 for HAD-D8). Peripheral risk factors (knee injury re-
ported at baseline and constitutional mal-alignment) had no sig-
niﬁcant effect on risk of incident KP. However, new knee injury
during follow-up was a strong risk factor for KP onset (OR 69.27,
95%CI 24.15, 198.7). BMI and presence of any comorbidity were also
risk factors for incident KP. The relationship of each baseline risk
factor to development of incident KP is presented in Table II and
Appendix 7.
The PRC of central and peripheral risk factors to incident KP was
14% and 29% respectively (Fig. 1).
Risk factors for KP worsening
In people with KP both central and peripheral risk factors
contributed to KP worsening during 1 year. The following central
factors associatedwithworsening: pain catastrophising (OR2.27, 95%
CI 1.83, 2.83 PCS9), depression (OR 1.85, 95% CI 1.46, 2.34), anxiety
(OR 1.68, 95% CI 1.35, 2.08) and WSP (OR 1.68, 95% CI 1.35, 2.10). In
addition, those with neuropathic-like pain and higher ICOAP scores
(both intermittent and constant) were more likely to report wors-
ening (Table II, Appendix 8). With respect to peripheral factors, sig-
niﬁcant injury before baseline did not associate with worsening KP,
whereas injury during follow-up) did (OR 2.52, 95% CI 1.48, 4.30).
Current varus mal-alignment (OR 2.28, 95% CI 1.30, 4.02) and high
risk occupation also associated. Other risk factors such as nodal hand
OA (OR 1.62, 95% CI 1.23, 2.14), presence of any comorbidity (OR 1.29,
95% CI 1.02, 1.64) and BMI associated with KP worsening.
The sensitivity analysis using an alternative deﬁnition of KP
worsening showed that only nodal OA and high risk occupation
predicted increase in KP severity from baseline (Appendix 9).
Overall, the contribution from peripheral factors to KP wors-
ening was much smaller (PRC ¼ 5%) than that from central factors
(PRC ¼ 29%) (Fig. 1).
Discussion
This is the ﬁrst community-based cohort study to investigate the
contribution of central and peripheral risk factors associated with
KP prevalence, incidence and progression. Central factors were
those related to pain perception, psychological and behavioural
response that could affect normal pain physiology39, while pe-
ripheral factors were those related to structural changes in the
knee. Some risk factors such as comorbidities and nodal hand OA
could inﬂuence KP through both central and peripheral mecha-
nisms so were classiﬁed as “other” risk factors. The main ﬁndings
are1: both central and peripheral risk factors associated with
prevalence of KP2; peripheral risk factors such as knee injury
contributed more to incidence of KP; and3 central risk factors such
as PCS contributed more to KP progression.
We examined central (e.g., WSP, anxiety, depression, cata-
strophizing), peripheral (e.g., injury and mal-alignment) and other
risk factors and conﬁrm that many of these associate with KP
(Table II). Some, such as WSP and comorbidities appear to act
particularly as risk factors for developing KP, whereas others such
as neuropathic-like pain, pain catastrophizing and current varus
mal-alignmentmay in part result fromKP and particularly associatewith pain progression. Furthermore, localised KP or OA might have
reciprocal effects on incident depression or WSP which later
contribute to worsening of symptoms40e42. For each outcome
(prevalent, incident and worsening of KP) we performed a two-
stage analysis. Firstly, we examined the association between in-
dependent risk factors and KP using OR as a measure of association.
Secondly, we explored the relative contribution of risk factors in
composite divided into three main groups (central, peripheral and
others) using PRC.
The positive association between depression and KP worsening
accords with two large longitudinal studies of people with KP and
knee OA43,44. The contribution of anxiety to KP worsening has been
reported previously by Mallen et al. (2007)45. In a study by Jinks
et al. (2008) WSP (two or more pain sites) was associated with
onset but not progression of KP17. However, our study showed a
strong association with KP for WSP and depression in the cross-
sectional analysis, and also convincing evidence of a causal rela-
tionship from the two sub-cohort studies of incidence and pro-
gression of KP in one year. A consistent association between
prevalence, incidence or worsening of KP and central risk factors
highlights the important contribution of centrally-mediated
mechanisms to the natural history of KP, supporting the concept
that KP shares risk factors in common with other chronic pain
disorders such as ﬁbromyalgia and low back pain46,47.
Major knee trauma is a recognised important risk factor for knee
OA onset14. In our study, previous knee injury was a strong risk
factor for KP in the cross-sectional analysis, and new injury asso-
ciated with both incidence and progression of KP (Table II). How-
ever, the association between some peripheral factors and KP in our
study did not always replicate ﬁndings from some previous cohort
(mainly knee OA) studies. For example, although constitutional
(early life) varus/valgusmal-alignmentwas a risk factor for incident
KP in a study by Ingham et al. (2011)48, we found no association
between constitutional malalignment and incidence or progression
of KP. The literature about effect of constitutional mal-alignment on
KP is limited15. However, our ﬁndings that current knee mal-
alignment, which is more likely a consequence of knee OA, is a
stronger predictor for progression of KP accords with other
literature15,49.
We additionally examined the relative contribution of central
and peripheral risk factors in a full risk model using a proportion
derived from ROC curve analysis (PRC). For incident KP the
contribution of peripheral factors was larger than that of central
factors (29% vs 14%), whereas for worsening KP the contribution of
central factors was larger than that of peripheral factors (29% vs
5%). This suggests that the relative contribution of central and pe-
ripheral risk factors to KP may differ at different stages of the
condition (development or progression). Incident KP is not often
centrally driven, however the inﬂuence of central risk factors
(existing before or developing later due to chronic pain) increases
as the condition progresses50,51.
There are a number of caveats to this study. Firstly, the overall
prevalence of KP in this population (45%) was slightly higher than
most previous studies (e.g., 28% in a previous Nottingham study24).
This may reﬂect response bias in that people with KP may more
likely respond to a KP questionnaire. Indeed comparison between
responders and non-responders to the Year-1 questionnaire
showed that people with KP and those with higher pain severity
were more likely to respond (Appendix 2). Secondly, previous
studies showed that the question we used to deﬁne KP is the most
sensitive (58.7%) but least speciﬁc (59.1%) predictor of grade 1
osteophytes24 and applying a different KP deﬁnition might give
different results. Thirdly, pain and risk factors were measured at
Non-Responders
(N ¼ 4769)
Responders
(N ¼ 4737)
P-value*
Age (years), mean (SD) 61.73 (10.96) 62.47 (10.14) 0.0011
Women, n (%) 2631 (55.17) 2740 (57.84) 0.0291
BMI, mean (SD) 27.37 (5.30) 27.26 (5.30) 0.3164
Pain severity (NRS 0e10)y,
mean (SD)
1.78 (2.90) 2.15 (3.00) <0.0001
Knee pain, n (%) 1892 (39.67) 2396 (50.58) <0.0001
GP-diagnosed knee OA, n (%) 557 (11.68) 722 (15.24) <0.0001
Widespread pain 960 (20.13) 1110 (23.43) 0.0001
HADS anxiety score 8 1623 (34.04) 1460 (30.81) 0.0008
HADS depression score 8 940 (19.71) 767 (16.19) <0.0001
PCS in the highest tertile (9) 1647 (34.56) 1609 (33.97) 0.5441
mPDQ  19 184 (3.86) 202 (4.26) 0.3180
Signiﬁcant injury 662 (14.48) 889 (19.18) <0.0001
Early varus malalignment 141 (3.40) 174 (3.98) 0.1594
Early valgus malalignment 95 (2.31) 87 (2.02) 0.3596
Varus malalignment 72 (1.68) 72 (1.60) 0.7605
Valgus malalignment 77 (1.80) 87 (1.93) 0.6434
High risk occupation 2053 (43.06) 1926 (40.65) 0.0173
2D4D ratio (type 3) 2124 (48.59) 2360 (51.93) 0.0017
Nodal OA 471 (10.40) 589 (12.92) 0.0002
ICOAP intermittent in
the highest tertile (7)
664 (13.93) 835 (17.62) <0.0001
ICOAP constant in the
highest tertile (7)
699 (14.66) 792 (16.72) 0.0059
Abbreviations: SD - standard deviation; BMI - body mass index; NRS e numerical
rating scale (range 0e10).
* t-test for continuous and chi-square test for categorical.
y Average pain severity in the past month.
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might reveal different trajectories of KP progression and better
determination of associations. Fourthly, both deﬁnitions for wors-
ening were self-reported andmay have limitations. PGA reﬂects the
perception of worsening (i.e., retrospective perspective by the
participant at the time of Y1 assessment) for the full course of the
disease but the risk factors captured at baseline may have changed
since the start of the disease (Table II). In contrast, NRS was
measured at only two time points during a short time period - one
year, which cannot reﬂect the actual pain trajectory. Fifthly, we
interpret our data as showing risk from central and peripheral
factors, but cannot exclude possible confounding by other factors.
Furthermore, the number of peripheral factors studied was limited.
The use of imaging and clinical assessments would have allowed
more detailed assessment of abnormal joint features and changes
in knee alignment over time. However, this would not affect the
examination of the relative contribution of the questionnaire based
surrogate measures of peripheral risk factors in different stages of
KP. Finally, this is the ﬁrst time that we have used this measure for
PRC of central or peripheral risk factors. A caveat of this measure is
that it increases with number of risk factors collected. However,
when we compare the same group of risk factors across different
stages of a disease, e.g., early (incidence) and later (progression)
stages of KP, relative PRCs can be determined. As with the original
measure of AUC, the derivedmeasure of PRC is also open to bias due
to model overﬁtting especially when the sample size is small.
However, this study involved a large sample of 9506 community-
derived participants so overﬁtting is unlikely to be an important
issue52.
In conclusion, this study conﬁrms that a number of peripheral
and central risk factors associate with prevalence of KP. While pe-
ripheral risk factors such as joint injury appear the main drivers for
development of KP, central factors such as PCS appear the main
drivers for KP progression. Further study is needed to examine the
contribution of other peripheral risk factors such as radiographic
change, synovial changes and muscle strength, as well as more
objective central risk factor measures such as quantitative sensory
testing and neuroimaging.
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Appendix 1. Clinical characteristics of the responders and
non-responders to the Year 1 questionnaire
A. Sarmanova et al. / Osteoarthritis and Cartilage 26 (2018) 1461e14731468Appendix 2. Recruitment of participants in the KPIC study.Questionnaires returned - 9506
Recruitment Questionnaire delivered 
to surgeries - 40,505
Consent for Further Research - 6716
Questionnaires returned - 4737
Year 1
Baseline
No pain at baseline – 2341
(of them 285 developed incident KP)
Knee pain at baseline - 2396
(of them 453 reported worsening of pain)Appendix 3. High risk occupation category, ﬁlter searches and
links to supporting literatureAgreed high risk category Filter searches References
Auto-industry/mechanic Car Fitter, Car Seat Assembly, Paint Sprayer/Car Repair (seat
assembler, reconditioning, painting), car mechanic, car
repairer, Panel beater
1
Tradesmen: construction Brick, Build, Property, Construction, Scaffold, Damp, Ground
worker, Quarry worker/operative, roof, Joiner, Carpenter,
Wood, Fitter, Sign maker, Furniture design and
manufacture, Upholsterer, Cabinet Maker, Shop Fitter,
Window, Glazing, Glazier, Double Glazier
1,2,3
Tradesmen: other Electric, Jointer Electrical, Lineman, Panel wirer/wireman,
Carpet, Floor, Slab, Paint, Plaster, Cabinet Sprayer, Plumber,
Pipe Fitter
1,2,3
Emergency services Police, Fireﬁghter, Army, Soldier, National Service, RAF,
Marines, Navy, Naval, Paratrooper, Royal (air force etc.),
Ambulance, Paramedic, Military, WRNS (Women's Royal
Navy Service)
Factory/warehouse worker Factory, Workshop, Worker, Assembly, Production,
Warehouse, Picker, Packer
4
Land management/cultivation Agriculture, Agricultural, Farm, Farmer, “Picker (fruits)”,
Herdsman, Dairy man, Gardener, Green, Landscape, Lawn,
Horticulture, Groundsman, Greenkeeper, Horticulturalist,
Timber yard worker, forest worker, forester, forestry
1,2
Manual workers engineering Engineer, Millwright, Lagger (Insulators)/Lagging 3
Health Services Nurse, Nursing, carer, care worker, care assistant, support
worker, Home help, RGN (registered general nurse), RNMH
2,5
(continued )
Agreed high risk category Filter searches References
(registered nurse mental health), Ward Orderly, SRN (State
Registered Nurse), RMN (Registered Mental Nurse), RNLD
Coal miner Coal, Mine, Colliery, Down pit, Mining, Collier 3
Metal worker Steel, Weld, Metal, Blacksmith, Foundry, Moulder, Plater,
Fabricator
1
PCM (Porters,
cleaners, maintenance)
Porter, Clean Window, Cleaner, Valeter, Wash (Car), Janitor,
Domestic Assistant, Chambermaid, Hospital domestic,
domestic, caretaker, building maintenance, maintenance,
handyman, building assistant
1,3
PE teacher PE, Physical 3
Postman Post, mail Agreed in Consensus
Meeting due to
prolongued walking,
bending and lifting.
Labourer Labourer, Pipe yard Worker, Concrete, Installer, Mason,
Fibre glass, Asphalt(er), Digging trenches, Fencer, Manual
4,6
Road worker Roadworks, Road, Highway, Platelayer, Tarmac layer,
Tarmacer
4
Shipyard worker Shipwright 1,3
Sports-other Any, Climbing instructor, Parachute instructor
1 Coggon D, Croft P, Kellingray S, et al. Occupational physical activities and osteoarthritis of the knee. Arthritis and rheumatism 2000;43(7):1443-9. doi: 10.1002/1529-
0131(200007)43:7<1443::aid-anr5>3.0.co;2-1 [published Online First: 2000/07/21]
2 Andersen S, Thygesen LC, Davidsen M, et al. Cumulative years in occupation and the risk of hip or knee osteoarthritis in men and women: a register-based follow-up study.
Occup Environ Med 2012;69(5):325-30. doi: 10.1136/oemed-2011-100033 [published Online First: 2012/01/14]
3 Pensions IIACaDfWa. Disorders of the knee: report by the Industrial Injuries Advisory Council, 1995.
4 Palmer KT. Occupational activities and osteoarthritis of the knee. British medical bulletin 2012;102:147-70. doi: 10.1093/bmb/lds012
5 Companies DS. Hardest Working Knees: Occupational Activities That Can Cause or Aggravate Knee Osteoarthritis. Information Sheet 2015 [Available from: https://
www.depuysynthes.com/binary/org/DPY_SYN/knee/campaigns/HWK_Backgrounder_12_02_15FINAL.pdf.]
6 Lindberg H, Montgomery F. Heavy labor and the occurrence of gonarthrosis. Clinical orthopaedics and related research 1987(214):235-36.
A. Sarmanova et al. / Osteoarthritis and Cartilage 26 (2018) 1461e1473 1469Appendix 4. The presence of comorbidity at baselineTotal No KP (Q11) Knee pain (Q11) P-value
N 9506 5218 4288
Conditions
High cholesterol, n (%) 2634 (27.71) 1356 (26.00) 1278 (29.80) <0.0001
Heart attack/angina, n (%) 604 (6.35) 287 (5.50) 317 (7.39) 0.0002
Hypertension, n (%) 2845 (29.93) 1400 (26.85) 1445 (33.70) <0.0001
Diabetes, n (%) 899 (9.46) 423 (8.11) 476 (11.10) <0.0001
Underactive/overactive thyroid, thyroiditis, n (%) 369 (3.88) 185 (3.54) 184 (4.29) 0.0608
Stroke, n (%) 271 (2.85) 142 (2.72) 129 (3.01) 0.4045
Multiple sclerosis, n (%) 18 (0.19) 10 (0.19) 8 (0.19) 0.9551
Irritable bowel syndrome, n (%) 963 (10.13) 427 (8.19) 536 (12.50) <0.0001
Fibromyalgia, n (%) 246 (2.59) 68 (1.30) 178 (4.15) <0.0001
Chronic fatigue syndrome, n (%) 133 (1.40) 55 (1.05) 78 (1.82) 0.0016
Chronic obstructive pulmonary disease (COPD), n (%) 103 (1.08) 54 (1.03) 49 (1.14) 0.6126
Asthma, n (%) 412 (4.33) 212 (4.06) 200 (4.66) 0.1514
Idiopathic pulmonary ﬁbrosis, n (%) 3 (0.03) 3 (0.06) 0 (0.00) 0.1164
Liver cirrhosis, n (%) 6 (0.06) 4 (0.08) 2 (0.05) 0.5622
Hepatitis, n (%) 5 (0.05) 2 (0.04) 3 (0.07) 0.5031
Non-alcoholic fatty liver disease, n (%) 6 (0.06) 4 (0.08) 2 (0.05) 0.5622
Rheumatoid arthritis, n (%) 92 (0.97) 25 (0.48) 67 (1.56) <0.0001
Ankylosing spondylitis, n (%) 19 (0.20) 3 (0.06) 16 (0.37) 0.0006
Lupus, n (%) 12 (0.13) 4 (0.08) 8 (0.19) 0.1331
Psoriatic arthritis, n (%) 17 (0.18) 4 (0.08) 13 (0.30) 0.0093
Systems affected
Cardiovascular disease, n (%) 4124 (43.38) 2105 (40.34) 2019 (47.08) <0.0001
Endocrine disease, n (%) 1229 (12.93) 595 (11.40) 634 (14.79) <0.0001
Non-restorative pain disorders, n (%) 1164 (12.24) 497 (9.52) 667 (15.56) <0.0001
Lung disease, n (%) 497 (5.23) 263 (5.04) 234 (5.46) 0.3624
Liver disease, n (%) 17 (0.18) 10 (0.19) 7 (0.16) 0.7447
Chronic kidney disease/failure (CKD), n (%) 23 (0.24) 8 (0.15) 15 (0.35) 0.0523
Central nervous system disorders, n (%) 289 (3.04) 152 (2.91) 137 (3.19) 0.4246
Gout, n (%) 94 (0.99) 54 (1.03) 40 (0.93) 0.6175
Chronic rheumatic conditions, n (%) 138 (1.45) 35 (0.67) 103 (2.40) <0.0001
Comorbidity count
N of comorbidities, mean (SD), n (%) 0.80 (0.85) 0.71 (0.81) 0.90 (0.90) <0.0001
Any comorbidities, n (%) 5355 (56.33) 2740 (52.51) 2615 (60.98) <0.0001
Any comorbidities  2, n (%) 1804 (18.98) 822 (15.75) 982 (22.90) <0.0001
Any comorbidities  3, n (%) 367 (3.86) 137 (2.63) 230 (5.36) <0.0001
Any comorbidities  4, n (%) 45 (0.47) 19 (0.36) 26 (0.61) 0.0868
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Total No KP KP Crude Age, gender, BMI-adjusted
N 9506 5218 4288
Central risk factors
Widespread pain, n (%) 2070 (21.77) 683 (13.09) 1387 (32.35) 3.17 (2.86; 3.52) 3.02 (2.71; 3.37)
HADS anxiety score 8, n (%) 3083 (32.43) 1349 (25.85) 1734 (40.44) 1.95 (1.79; 2.12) 1.87 (1.71; 2.06)
HADS depression score 8, n (%) 1707 (17.96) 593 (11.36) 1114 (25.98) 2.74 (2.45; 3.05) 2.40 (2.14; 2.70)
PCS in the highest tertile (9), n (%) 3256 (34.25) 1354 (25.96) 1902 (44.37) 2.27 (2.09; 2.48) 2.06 (1.88; 2.25)
Peripheral risk factors
Signiﬁcant injury, n (%) 1551 (16.31) 352 (6.97) 1199 (28.83) 5.40 (4.76; 6.14) 5.62 (4.92; 6.42)
Early varus malalignment, n (%) 315 (3.31) 147 (3.18) 168 (4.31) 1.37 (1.09; 1.72) 1.49 (1.18; 1.88)
Early valgus malalignment, n (%) 182 (1.91) 71 (1.56) 111 (2.88) 1.87 (1.38; 2.53) 1.72 (1.25; 2.36)
Varus malalignment, n (%) 144 (1.51) 23 (0.49) 121 (2.99) 6.31 (4.03; 9.88) 5.43 (3.44; 8.58)
Valgus malalignment, n (%) 164 (1.73) 35 (0.74) 129 (3.19) 4.42 (3.03; 6.44) 4.18 (2.74; 6.38)
High risk occupation, n (%) 3979 (41.85) 1973 (37.80) 2006 (46.78) 1.45 (1.33; 1.57) 1.43 (1.31; 1.56)
2D4D ratio (type 3), n (%) 4484 (47.17) 2439 (49.86) 2045 (50.81) 1.04 (0.96; 1.13) 1.04 (0.95; 1.14)
Other risk factors
Age, mean (SD)* 62.10 (10.56) 62.33 (10.69) 61.82 (10.40) 1.00 (0.99; 1.00) 1.00 (0.99; 1.00)
Women, n (%)y 5371 (56.50) 2909 (56.03) 2462 (57.62) 1.07 (0.98; 1.16) 1.10 (1.01; 1.20)
BMI (kg/m2), mean (SD)z 27.31 (5.30) 26.36 (4.63) 28.47 (5.80) 1.08 (1.07; 1.09) 1.08 (1.07; 1.09)
Nodal OA, n (%) 1060 (11.15) 445 (8.86) 615 (15.11) 1.83 (1.61; 2.08) 1.89 (1.64; 2.17)
N of comorbidities, mean (SD), n (%) 0.80 (0.85) 0.71 (0.81) 0.90 (0.90) 1.29 (1.23; 1.36) 1.21 (1.15; 1.28)
Any comorbidities, n (%) 5355 (56.33) 2740 (52.51) 2615 (60.98) 1.41 (1.30; 1.53) 1.29 (1.18; 1.42)
Any comorbidities  2, n (%) 1804 (18.98) 822 (15.75) 982 (22.90) 1.59 (1.43; 1.76) 1.37 (1.22; 1.53)
Any comorbidities  3, n (%) 367 (3.86) 137 (2.63) 230 (5.36) 2.10 (1.69; 2.61) 1.68 (1.34; 2.11)
Any comorbidities  4, n (%) 45 (0.47) 19 (0.36) 26 (0.61) 1.67 (0.92; 3.03) 1.51 (0.80; 2.84)
In bold - If a 95% conﬁdence interval does not include the null value (i.e. there is a statistically meaningful or statistically signiﬁcant difference between the groups).
Abbreviations: BMI - body mass index; KP e knee pain; OR e odds ratio; CI econﬁdence interval; HADS - Hospital Anxiety and Depression Scale; PCS - Pain Catastrophizing
Scale; SD e standard deviation.
* Adjusted for gender and BMI only.
y Adjusted for age and BMI only.
z Adjusted for age and gender only.Appendix 6. Contribution of central, peripheral and other
risk factors to knee painOutcome Model AUC (95%CI) PRC
Prevalent KP Full 0.76 (0.74; 0.77) 100%
without central 0.71 (0.70; 0.72) 19%
without peripheral 0.70 (0.69; 0.71) 23%
without others 0.69 (0.67; 0.70) 27%
Incident KP Full* 0.71 (0.68; 0.75) 100%
without central 0.68 (0.64; 0.72) 14%
without peripheral 0.65 (0.62; 0.69) 29%
without others 0.68 (0.64; 0.72) 14%
Worsening KP Full* 0.71 (0.68; 0.73) 100%
without central 0.65 (0.62; 0.68) 29%
without peripheral 0.70 (0.67; 0.73) 5%
without others 0.68 (0.65; 0.71) 14%
Risk factors included in the full model:
 Central: Widespread pain; HADS - Hospital Anxiety and Depression Scales; PCS - Pain Catastrophizing Scale.
 Peripheral: History of signiﬁcant injury; early life mal-alignment; current mal-alignment; high risk occupation.
 Others: Age; gender; BMI; number of comorbidities; nodal hand osteoarthritis.
Abbreviations: AUC e area under the curve; CI econﬁdence interval. PRC e proportional risk contribution.
* New knee injury (past 12 months) as an additional peripheral risk factor was included in analysis.
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Total No KP Incident KP Crude Age, gender, BMI-adjusted
N 2341 2056 285
Central risk factors
Widespread pain at baseline, n (%) 316 (13.50) 247 (12.01) 69 (24.21) 2.34 (1.73; 3.16) 2.23 (1.63; 3.06)
HADS anxiety score 8 at baseline, n (%) 559 (23.88) 477 (23.20) 82 (28.77) 1.34 (1.02; 1.76) 1.27 (0.95; 1.70)
HADS depression score 8 at baseline, n (%) 216 (9.23) 169 (8.22) 47 (16.49) 2.21 (1.55; 3.13) 1.99 (1.38; 2.87)
PCS in the highest tertile (9) at baseline, n (%) 611 (26.1) 524 (25.50) 87 (30.63) 1.29 (0.98; 1.69) 1.14 (0.86; 1.52)
Peripheral risk factors
Signiﬁcant injury at baseline, n (%) 183 (7.82) 158 (7.85) 25 (8.90) 1.15 (0.74; 1.78) 1.08 (0.68; 1.72)
New injury (past 12 months), n (%) 38 (1.62) 4 (0.19) 34 (11.93) 69.49 (24.46; 197.4) 69.27 (24.15; 198.7)
Early varus malalignment, n (%) 72 (3.07) 62 (3.25) 10 (3.86) 1.20 (0.61; 2.36) 1.28 (0.64; 2.57)
Early valgus malalignment, n (%) 28 (1.20) 23 (1.23) 5 (1.96) 1.60 (0.60; 4.26) 1.05 (0.36; 3.12)
High risk occupation, n (%) 833 (35.57) 732 (35.59) 101 (35.44) 0.99 (0.77; 1.29) 0.99 (0.76; 1.30)
2D4D ratio (type 3), n (%) 1171 (50.02) 1023 (51.10) 148 (54.81) 1.16 (0.90; 1.50) 1.18 (0.90; 1.54)
Other risk factors
Age (years), mean (SD)* 62.54 (10.25) 62.56 (10.28) 62.38 (10.09) 1.00 (0.99; 1.01) 1.00 (0.99; 1.01)
Women, n (%)y 1343 (57.37) 1170 (56.93) 173 (60.70) 1.17 (0.91; 1.51) 1.15 (0.89; 1.50)
BMI (kg/m2), mean (SD)z 26.20 (4.50) 26.04 (4.46) 27.36 (4.65) 1.06 (1.03; 1.09) 1.06 (1.03; 1.09)
Nodal OA, n (%) 225 (9.61) 188 (9.41) 37 (13.60) 1.52 (1.04; 2.21) 1.49 (0.99; 2.23)
N of comorbidities, mean (SD), n (%) 0.69 (0.79) 0.67 (0.77) 0.86 (0.90) 1.32 (1.14; 1.53) 1.31 (1.12; 1.53)
Any comorbidities, n (%) 1213 (51.82) 1039 (50.54) 174 (61.05) 1.53 (1.19; 1.98) 1.48 (1.13; 1.95)
Any comorbidities  2, n (%) 335 (14.30) 285 (13.86) 50 (17.54) 1.32 (0.95; 1.84) 1.26 (0.90; 1.78)
Any comorbidities  3, n (%) 62 (2.65) 46 (2.24) 16 (5.61) 2.60 (1.45; 4.66) 2.54 (1.41; 4.60)
Any comorbidities  4, n (%) 8 (0.34) 4 (0.19) 4 (1.40) 7.30 (1.82; 29.36) 8.85 (1.95; 40.16)
In bold - If a 95% conﬁdence interval does not include the null value (i.e. there is a statistically meaningful or statistically signiﬁcant difference between the groups).
Abbreviations: BMI - body mass index; KP e knee pain; OR e odds ratio; CI econﬁdence interval; HADS - Hospital Anxiety and Depression Scale; PCS - Pain Catastrophizing
Scale; SD - standard deviation.
* Adjusted for gender and BMI only.
y Adjusted for age and BMI only.Appendix 8. Risk factors associated with worsening of knee
pain at 1 year
z Adjusted for age and gender only.Descriptive OR (95% CI)
Total Stable/improved Worsened Crude Age, gender, BMI-adjusted
N 2396 1943 453
Central risk factors
Widespread pain, n (%) 794 (33.14) 594 (30.57) 200 (44.15) 1.80 (1.46; 2.21) 1.68 (1.35; 2.10)
HADS anxiety score 8, n (%) 900 (37.56) 678 (34.89) 222 (49.01) 1.79 (1.46; 2.20) 1.68 (1.35; 2.08)
HADS depression score 8, n (%) 551 (23.00) 394 (20.28) 157 (34.66) 2.09 (1.67; 2.61) 1.85 (1.46; 2.34)
PCS in the highest tertile (>¼9), n (%) 998 (41.65) 726 (37.36) 272 (60.04) 2.52 (2.04; 3.11) 2.27 (1.83; 2.83)
mPDQ  19, n (%) 202 (8.43) 123 (6.33) 79 (17.44) 3.13 (2.31; 4.23) 2.65 (1.92; 3.65)
ICOAP intermittent in the highest tertile (>¼7), n (%) 826 (34.47) 551 (28.36) 275 (60.71) 3.90 (3.15; 4.83) 3.61 (2.89; 4.50)
ICOAP constant in the highest tertile (>¼7), n (%) 788 (32.89) 518 (26.66) 270 (59.60) 4.06 (3.28; 5.02) 3.70 (2.96; 4.63)
Peripheral risk factors
Signiﬁcant injury at baseline, n (%) 706 (29.47) 583 (30.80) 123 (28.21) 0.88 (0.70; 1.11) 0.89 (0.70; 1.13)
Signiﬁcant injury in the past 12 months, n (%) 63 (2.63) 39 (2.01) 24 (5.31) 2.73 (1.62; 4.59) 2.52 (1.48; 4.30)
Early varus malalignment, n (%) 102 (4.26) 76 (4.23) 26 (6.31) 1.53 (0.96; 2.41) 1.60 (0.99; 2.58)
Early valgus malalignment, n (%) 59 (2.46) 44 (2.48) 15 (3.75) 1.54 (0.85; 2.79) 1.64 (0.89; 3.03)
Varus malalignment, n (%) 61 (2.55) 41 (2.21) 20 (4.67) 2.17 (1.26; 3.75) 2.28 (1.30; 4.02)
Valgus malalignment, n (%) 68 (2.84) 55 (2.96) 13 (3.04) 1.03 (0.56; 1.90) 0.71 (0.37; 1.37)
High risk occupation, n (%) 1093 (45.62) 867 (44.62) 226 (49.89) 1.24 (1.01; 1.52) 1.29 (1.04; 1.60)
2D4D ratio (type 3), n (%) 1188 (49.58) 979 (52.89) 209 (49.64) 0.88 (0.71; 1.09) 0.86 (0.69; 1.07)
Other risk factors
Age (years), mean (SD)* 62.41 (10.02) 62.26 (9.98) 63.03 (10.19) 1.01 (1.00; 1.02) 1.01 (1.00; 1.02)
Women, n (%)y 1397 (58.31) 1107 (56.97) 290 (64.02) 1.34 (1.09; 1.66) 1.34 (1.07; 1.66)
BMI (kg/m2), mean (SD)z 28.29 (5.80) 27.93 (5.62) 29.83 (6.28) 1.05 (1.03; 1.07) 1.05 (1.04; 1.07)
Nodal OA, n (%) 364 (15.19) 269 (14.44) 95 (22.35) 1.71 (1.31; 2.22) 1.62 (1.23; 2.14)
N of comorbidities, mean (SD), n (%) 0.90 (0.90) 0.87 (0.89) 1.05 (0.91) 1.24 (1.11; 1.39) 1.13 (1.00; 1.27)
Any comorbidities, n (%) 1461 (60.98) 1152 (59.29) 309 (68.21) 1.47 (1.19; 1.83) 1.29 (1.02; 1.64)
Any comorbidities  2, n (%) 553 (23.08) 419 (21.56) 134 (29.58) 1.53 (1.22; 1.92) 1.26 (0.98; 1.61)
Any comorbidities  3, n (%) 127 (5.30) 99 (5.10) 28 (6.18) 1.23 (0.80; 1.89) 0.98 (0.62; 1.54)
Any comorbidities  4, n (%) 14 (0.58) 11 (0.57) 3 (0.66) 1.17 (0.33; 4.21) 0.70 (0.15; 3.18)
In bold - If a 95% conﬁdence interval does not include the null value (i.e. there is a statistically meaningful or statistically signiﬁcant difference between the groups).
Abbreviations: BMI - body mass index; KP e knee pain; OR e odds ratio; CI econﬁdence interval; HADS - Hospital Anxiety and Depression Scale; PCS - Pain Catastrophizing
Scale; SD - standard deviation; mPDQ e modiﬁed Pain Detect Questionnaire; ICOAP - Measure of Intermittent and Constant Osteoarthritis Pain.
* Adjusted for gender and BMI only.
y Adjusted for age and BMI only.
z Adjusted for age and gender only.
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of knee pain on NRS (≥1*) at 1 yearDescriptive OR (95% CI)
Total Stable/improved Worsened Crude Age, gender, BMI-adjusted
N 2396 1738 658
Central risk factors
Widespread pain, n (%) 794 (33.14) 561 (32.28) 233 (35.41) 1.15 (0.95; 1.39) 1.11 (0.92; 1.35)
HADS anxiety score 8, n (%) 900 (37.56) 642 (36.94) 258 (39.21) 1.10 (0.92; 1.32) 1.09 (0.90; 1.31)
HADS depression score 8, n (%) 551 (23.00) 398 (22.90) 153 (23.25) 1.02 (0.82; 1.26) 1.00 (0.80; 1.24)
PCS in the highest tertile (9), n (%) 998 (41.65) 722 (41.54) 276 (41.95) 1.02 (0.85; 1.22) 1.01 (0.84; 1.22)
mPDQ  19, n (%) 202 (8.43) 160 (9.21) 42 (6.38) 0.67 (0.47; 0.96) 0.63 (0.44; 0.91)
ICOAP intermittent in the highest tertile (7), n (%) 826 (34.47) 616 (35.44) 210 (31.91) 0.85 (0.71; 1.03) 0.81 (0.66; 0.99)
ICOAP constant in the highest tertile (7), n (%) 788 (32.89) 584 (33.60) 204 (31.00) 0.89 (0.73; 1.08) 0.82 (0.67; 1.00)
Peripheral risk factors
Signiﬁcant injury at baseline, n (%) 706 (29.47) 497 (29.30) 209 (32.45) 1.16 (0.95; 1.41) 1.18 (0.96; 1.44)
Signiﬁcant injury in the past 12 months, n (%) 63 (2.63) 40 (2.31) 23 (3.51) 1.54 (0.91; 2.59) 1.43 (0.84; 2.44)
Early varus malalignment, n (%) 102 (4.26) 76 (4.73) 26 (4.32) 0.91 (0.58; 1.43) 0.89 (0.56; 1.42)
Early valgus malalignment, n (%) 59 (2.46) 42 (2.66) 17 (2.85) 1.08 (0.61; 1.91) 1.02 (0.57; 1.85)
Varus malalignment, n (%) 61 (2.55) 48 (2.89) 13 (2.08) 0.71 (0.38; 1.32) 0.66 (0.35; 1.27)
Valgus malalignment, n (%) 68 (2.84) 52 (3.13) 16 (2.56) 0.81 (0.46; 1.43) 0.80 (0.45; 1.43)
High risk occupation, n (%) 1093 (45.62) 764 (43.96) 329 (50.00) 1.27 (1.07; 1.53) 1.30 (1.07; 1.56)
2D4D ratio (type 3), n (%) 1188 (49.58) 854 (51.66) 334 (53.96) 1.10 (0.91; 1.32) 1.11 (0.92; 1.34)
Other risk factors
Age (years), mean (SD)y 62.41 (10.02) 62.48 (9.96) 62.22 (10.20) 1.00 (0.99; 1.01) 1.00 (0.99; 1.01)
Women, n (%)z 1397 (58.31) 997 (57.36) 400 (60.79) 1.15 (0.96; 1.38) 1.15 (0.96; 1.39)
BMI (kg/m2), mean (SD)x 28.29 (5.80) 28.21 (5.62) 28.50 (6.25) 1.01 (0.99; 1.02) 1.01 (0.99; 1.02)
Nodal OA, n (%) 364 (15.19) 248 (14.87) 116 (18.71) 1.32 (1.03; 1.68) 1.34 (1.04; 1.72)
N of comorbidities, mean (SD), n (%) 0.90 (0.90) 0.90 (0.91) 0.89 (0.86) 0.98 (0.89; 1.09) 0.95 (0.85; 1.06)
Any comorbidities, n (%) 1461 (60.98) 1053 (60.59) 408 (62.01) 1.06 (0.88; 1.28) 1.05 (0.86; 1.28)
Any comorbidities  2, n (%) 553 (23.08) 407 (23.42) 146 (22.19) 0.93 (0.75; 1.16) 0.88 (0.70; 1.10)
Any comorbidities  3, n (%) 127 (5.30) 99 (5.70) 28 (4.26) 0.74 (0.48; 1.13) 0.66 (0.42; 1.03)
Any comorbidities  4, n (%) 14 (0.58) 11 (0.63) 3 (0.46) 0.72 (0.20; 2.59) 0.46 (0.10; 2.07)
In bold - If a 95% conﬁdence interval does not include the null value (i.e. there is a statistically meaningful or statistically signiﬁcant difference between the groups).
Abbreviations: BMI - body mass index; KP e knee pain; OR e odds ratio; CI econﬁdence interval; HADS - Hospital Anxiety and Depression Scale; PCS - Pain Catastrophizing
Scale; SD e standard deviation; mPDQ e modiﬁed Pain Detect Questionnaire; ICOAP - Measure of Intermittent and Constant Osteoarthritis Pain.
* A signiﬁcant change from baseline was calculated using he least signiﬁcant criterion (LSC) (Nguyen and Eisman, 2000, Wang et al., 2016).
y Adjusted for gender and BMI only.
z adjuSted for age and BMI only.
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